Environmental, life-style, and physical precursors of clinical Parkinson's disease: Recent findings from the Honolulu-Asia Aging Study

Journal of Neurology, Supplement

Volumn 250, Issue 3, 2003, Pages 30-39

  Abbott, Robert D ^a,b,d,g   Ross, G Webster ^b,c,d,e   White, Lon R ^b,c,d,e   Sanderson, Wayne T ^f   Burchfiel, Cecil M ^f   Kashon, Michael ^f   Sharp, Dan S ^f   Masaki, Kamal H ^b,d,e   Curb, J David ^b,d,e   Petrovitch, Helen ^b,c,d,e  

^a UNIVERSITY OF VIRGINIA   (United States)

^b PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d KUAKINI MEDICAL CENTER   (United States)

^e UNIVERSITY OF HAWAII   (United States)

^f NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^g UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Epidemiology; Parkinson's disease; Risk factor

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA TOCOPHEROL; ASCORBIC ACID; CHOLESTEROL; COBALAMIN; LEVODOPA; MONOUNSATURATED FATTY ACID; NICOTINIC ACID; PANTOTHENIC ACID; PESTICIDE; POLYUNSATURATED FATTY ACID; PROTEIN; RETINOL; RIBOFLAVIN; ROTENONE; VITAMIN B GROUP;

CARBOHYDRATE INTAKE; CARDIOVASCULAR DISEASE; CHOLESTEROL INTAKE; CIGARETTE SMOKING; COFFEE; CONFERENCE PAPER; CONSTIPATION; ENVIRONMENTAL FACTOR; FOLLOW UP; HUMAN; LIFESTYLE; MORBIDITY; NEUROTOXICITY; NONHUMAN; OBESITY; PARKINSON DISEASE; PLANTATION; PRIORITY JOURNAL; PROCESSING; SUGARCANE;

AGED; AGED, 80 AND OVER; AGING; ASIA; BODY COMPOSITION; COFFEE; CONSTIPATION; DIET; ENVIRONMENTAL EXPOSURE; HUMANS; INCIDENCE; LIFE STYLE; MALE; MIDDLE AGED; PARKINSON DISEASE; PESTICIDES; RISK FACTORS; SMOKING;

EID: 10744227681     PISSN: 09391517     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW (2001) Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 57:456-462
2. Abbott RD, Ross GW, White LR, Nelson JS, Masaki KH, Tanner CM, Curb JD, Blanchette PL, Popper JS, Petrovitch H (2002) Mid-life adiposity and the future risk of Parkinson's disease. Neurology 59:1051-1057
3. Anderson C, Checkoway H, Franklin GM, Beresford S, Smith-Weller T, Swanson PD (1999) Dietary factors in Parkinson's disease: the role of food groups and specific foods. Mov Disord 14:21-27
4. Ashraf W, Pfeiffer RF, Park F, Lof J, Quigley EMM (1997) Constipation in Parkinson's disease: objective assessment and response to psyllium. Mov Disord 12:946-951
5. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3:1301-1306
6. Beyer PL, Palarino MY, Michalek D, Busenbark K, Koller WC (1995) Weight change and body composition in patients with Parkinson's disease. J Am Diet Assoc 95:979-983
7. Cox DR (1972) Regression models and life tables. J R Stat Soc 34(series B): 187-202
8. Durrieu GL, Lau ME, Rascol O, Senard JM, Rascol A, Montastruc JL (1992) Parkinson's disease and weight loss: a study with anthropometric and nutritional assessment. Clin Autonomic Res 2:153-157
9. Edwards LL, Quigley EMM, Pfeiffer RF (1992) Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology. Neurology 42: 726-732
10. Fearnly JM, Lees AJ (1991) Aging and Parkinson's disease: substantia nigra regional selectivity. Brain 114: 2283-2301
11. Gibb WRG, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:745-752
12. Gordon T (1957) Mortality experience among the Japanese in the United States, Hawaii, and Japan. Pub Health Reports 72:543-553
13. Grandinetti A, Morens D, Reed D, MacEachern D (1994) Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am J Epidemiol 139: 1129-38
14. Graves AB, van Duijn CM, Chandra V, Fratiglioni L, Heyman A, Jorm AF, Kokmen E, Kondo K, Mortimer JA, Rocca WA (1991) Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EU-RODEM Risk Factors Research Group. Int J Epidemiol 20 (Suppl 2):S48-S57
15. Heilbrun LK, Kagan A, Nomura A, Wasnich RD (1985) The origins of epidemiologic studies of heart disease, cancer and osteoporosis among Hawaii Japanese. Hawaii Med J 44: 294-296
16. Hellenbrand W, Boeing H, Robra B-P, Seidler A, Vieregge P, Nischan P, Joerg J, Oertel WH, Schneider E, Ulm G (1996) Diet and Parkinson's disease II: a possible role for the past intake of specific nutrients. Neurology 47: 644-650
17. Hosmer DW Jr, Lemeshow S (1989) Applied logistic regression. John Wiley, New York, pp 25-36
18. Jost WH (1997) Gastrointestinal motility problems in patients with Parkinson's disease: effects of antiparkinsonian treatment and guidelines for management. Drugs and Aging 10: 249-258
19. Kagan A, Harris BR, Winkelstein W Jr, Johnson KG, Kato H, Syme SL, Rhoads GG, Gay ML, Nichaman MZ, Hamiltion HB, Tillotson J (1974) Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary, and biochemical characteristics. J Chron Dis 27:345-364
20. Kagan A, Marmot MG, Kato H (1980) The Ni-Hon-San Study of cardiovascular disease epidemiology: population characteristics and epidemiology of stroke. In: Kesteloot H, Joossens JV (eds) Epidemiology of arterial blood pressure. Martinus Nijhoff Publishers, The Hague Boston London, pp 423-436
21. nd ed). Elsevier, New York, pp 211-221
22. Korczyn AD (1989) Autonomic nervous system screening in patients with early Parkinson's disease. In: Przuntek H, Riederer P (eds) Early diagnosis and preventive therapy in Parkinson's disease. Springer-Verlag, Vienna, pp 41-48
23. Lane PW, Nelder JA (1982) Analysis of covariance and standardization as instances of prediction. Biometrics 38: 613-621
24. Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of mepiridine-analog synthesis. Science 219: 979-980
25. Logroscino G, Marder K, Cote L, Tang M-X, Shea S, Mayeux R (1996) Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study. Ann Neurology 39:89-94
26. McGee D, Rhoads G, Hankin J, Yano K, Tillotson J (1982) Within-person variability of nutrient intake in a group of Hawaiian men of Japanese ancestry. Am J Clin Nutr 36:657-663
27. Mehta CR, Patel NR (1995) Exact logistic regression: theory and examples. Stat Med 14:2143-2160
28. 18F] dopa-PET and clinical study of the rate of progression in Parkinson's disease. Brain 119:585-591
29. Morens DM, Davis JW, Grandinetti A, Ross GW, Popper JS, White LR (1996) Epidemiologic observations on Parkinson's disease: incidence and mortality in a prospective study of middle-aged men. Neurology 46: 1044-1050
30. Morens DM, Grandinetti A, Waslien CI, Park CB, Ross GW, White LR (1996) Case-control study of idiopathic Parkinson's disease and dietary vitamin E intake. Neurology 46:1270-1274
31. Parkinson J (1817) An essay on the shaking palsy. Whittingham and Rowland, London
32. Petrovitch H, Ross GW, Abbott RD, Sanderson WT, Sharp DS, Tanner CM, Masaki KH, Blanchette PL, Popper JS, Foley D, White LR (2002) Plantation work and risk of Parkinson's disease in a population-based longitudinal study. Arch Neurology 59:1787-1792
33. Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung Ko-Hui, Tanner CM, Masaki KH, Blanchette PL, Curb JD, Popper JS, White LR (2000) Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 283: 2674-2679
34. Schoeller DA (1990) How accurate is self-reported dietary energy intake? Nutr Rev 48:373-379
35. Sriram K, Benkovic SA, Miller DB, O'Callaghan JP (2002) Obesity exacerbates chemically induced neurodegeneration. Neuroscience 115:1335-1346
36. Takeya Y, Popper JS, Shimizu Y, Kato H, Rhoads GG, Kagan A (1984) Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: incidence of stroke in Japan and Hawaii. Stroke 15:15-28
37. Thiruchelvam M, Brockel BJ, Richfield EK, Baggs RB, Cory-Slechta DA (2000) Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease? Brain Res 873:225-234
38. Thom TJ, Epstein FH, Feldman JJ, Leaverton PE, Wolz M (1992) Total mortality and mortality from heart disease, cancer, and stroke from 1950 to 1987 in 27 countries. Washington DC, National Institutes of Health, NIH publication no. 92-3088
39. Trabulsi J, Schoeller DA (2001) Evaluation of dietary assessment instruments against doubly labeled water, a biomarker of habitual energy intake. Am J Physiol Endocrinol Metab 281: E891-E899
40. US. Bureau of the Census, 1970 Census Population (1971) Alphabetical Index of Industries and Occupations. US. Government Printing Office, Washington, DC
41. van Duijn CM, Hofman A (1991) Relation between nicotine intake and Alzheimer's disease. BMJ 302: 1491-1494
42. Wang GJ, Volkow ND, Logan J, Pappas NR, Wood TC, Zhu W, Netusil N, Fowler JS (2001) Brain dopamine and obesity. Lancet 357:354-357
43. Ward CD, Gibb WR (1990) Research diagnostic criteria for Parkinson's disease. Adv Neurology 53:245-249
44. Worth RM, Kato H, Rhoads G, Kagan A, Syme SL (1975) Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Mortality. Am J Epidemiol 102:481-490
45. Yano K, Reed DM, McGee DL (1984) Ten-year incidence of coronary heart disease in the Honolulu Heart Program: relationship to biologic and lifestyle characteristics. Am J Epidemiol 119:653-666
46. Yano K, Reed DM, Kagan A (1985) Coronary heart disease, hypertension and stroke among Japanese-American men in Hawaii: The Honolulu Heart Program. Hawaii Med J 44:297-312
47. Zhang Z-X, Roman GC (1993) Worldwide occurrence of Parkinson's disease: an updated review. Neuroepidemiology 12:195-329